Specifications
Immunogen
Unpurified Influenza B Virus (B/Lee/40) for primary intranasal immunization, boosted intravenously with purified Influenza B Virus disrupted with Triton X-100 for 40 min at 37°C.
Applications
Application Notes
WB: Use at an assay dependent concentration. Predicted molecular weight: 62 kDa.
ICC/IF: Use at an assay dependent concentration. using acetone-fixation.
ELISA: Use at an assay dependent concentration.
Target
Alternative Names
NP; nucleocapsid protein;
Product Background
Antigen Description
Influenza A and B are the two types of influenza viruses that cause epidemic human disease. Influenza B viruses currently circulating are divided into two antigenically and genetically distinct groups: the Victoria and Yamagata lineages.
Pathway
Assembly of Viral Components at the Budding Site, organism-specific biosystem; Budding, organism-specific biosystem; Disease, organism-specific biosystem; Entry of Influenza Virion into Host Cell via Endocytosis, organism-specific biosystem; Export of Viral Ribonucleoproteins from Nucleus, organism-specific biosystem; Fusion and Uncoating of the Influenza Virion, organism-specific biosystem; Fusion of the Influenza Virion to the Host Cell Endosome, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-1285 in a publication?
Let us know and earn a reward for your research.